2 weeks Ago By ABMN Staff
Cerity Partners LLC cut its stake in Privia Health Group, Inc. ( NASDAQ:PRVA – Free Report ) by 15.3% in the 4th quarter, Holdings Channel reports.
The fund owned 11,626 shares of the company’s stock after selling 2,095 shares during the quarter. Cerity Partners LLC’s holdings in Privia Health Group were worth $213,000 at the end of the most recent reporting period. A number of other institutional investors have also added to or reduced their stakes in PRVA.
First Horizon Advisors Inc. boosted its holdings in shares of Privia Health Group by 53.8% in the 4th quarter.
First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Privia Health Group by 7,833.
3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares in the last quarter. Financial Management Professionals Inc.
purchased a new stake in Privia Health Group in the fourth quarter worth approximately $51,000. Quadrant Capital Group LLC grew its position in Privia Health Group by 11.8% during the fourth quarter.
Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after acquiring an additional 511 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its stake in shares of Privia Health Group by 185.7% during the fourth quarter.
Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock worth $98,000 after acquiring an additional 3,249 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.
Analyst Ratings Changes Several equities analysts recently commented on PRVA shares. Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.
00 and gave the company a “buy” rating in a report on Friday, February 28th. Truist Financial raised their price objective on Privia Health Group from $27.00 to $28.
00 and gave the company a “buy” rating in a research note on Thursday, April 10th. Stephens reissued an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd.
Robert W. Baird lifted their price target on Privia Health Group from $24.00 to $26.
00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. Finally, Piper Sandler boosted their price objective on Privia Health Group from $25.00 to $40.
00 and gave the company an “overweight” rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $27.
14. Insiders Place Their Bets In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the company’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.
38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.
88. This represents a 3.04 % decrease in their position.
The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website . 10.70% of the stock is currently owned by company insiders.
Privia Health Group Trading Up 0.3 % NASDAQ:PRVA opened at $23.46 on Friday.
Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $26.
04. The company has a 50-day moving average price of $23.68 and a 200-day moving average price of $21.
82. The stock has a market cap of $2.85 billion, a price-to-earnings ratio of 234.
62, a P/E/G ratio of 3.47 and a beta of 0.88.
Privia Health Group Company Profile ( Free Report ) Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. Featured Articles Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Privia Health Group, Inc. ( NASDAQ:PRVA – Free Report ). Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.
com's FREE daily email newsletter ..
